Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Berger

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|May 29, 2010
Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher diseaseJuliette Berger, Séverine Lecourt, Valérie Vanneaux, et al.
Stem Cells and Development|July 24, 2014
The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironmentAlexandre Janel, Frédérique Dubois-Galopin, Céline Bourgne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 22, 2020
Measurements of eftrenonacog alfa by 19 different combinations reagents/instrument: A single-centre studyThomas Sinegre, Adeline Trayaud, Maryse Tardieu, et al.
Cancer|October 26, 2025
Optimizing Wilms tumor 1 thresholds for measurable residual disease monitoring in acute myeloid leukemia: Improved sensitivity and concordance with nucleophosmin 1 in a single-center validation studySabrina Barriere, Céline Bourgne, Thomas Tassin, et al.
American Journal of Hematology|January 29, 2020
Semaphorin 7A: A novel marker of disease activity in Gaucher diseaseMélanie Franco, Nelly Reihani, Lucie Dupuis, et al.
Leukemia Research|January 24, 2015
Phosphorylation of spleen tyrosine kinase at tyrosine 348 (pSyk³⁴⁸) may be a marker of advanced phase of Chronic Myeloid Leukemia (CML)Céline Bourgne, Alexandre Janel, Juliette Berger, et al.
Annals of Hematology|January 23, 2025
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitorsManon Garcia, Carolyne Croizier, Grégory Lazarian, et al.
Annals of Hematology|August 30, 2022
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatorySandrine Saugues, Céline Lambert, Elisabeth Daguenet, et al.
Haematologica|April 21, 2019
Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy studyTatiana Raskovalova, Marc G Berger, Marie-Christine Jacob, et al.
British Journal of Haematology|March 3, 2024
Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-upBenjamin Lebecque, Joevin Besombes, Louis-Thomas Dannus, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|May 29, 2010
Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher diseaseJuliette Berger, Séverine Lecourt, Valérie Vanneaux, et al.
Stem Cells and Development|July 24, 2014
The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironmentAlexandre Janel, Frédérique Dubois-Galopin, Céline Bourgne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 22, 2020
Measurements of eftrenonacog alfa by 19 different combinations reagents/instrument: A single-centre studyThomas Sinegre, Adeline Trayaud, Maryse Tardieu, et al.
Cancer|October 26, 2025
Optimizing Wilms tumor 1 thresholds for measurable residual disease monitoring in acute myeloid leukemia: Improved sensitivity and concordance with nucleophosmin 1 in a single-center validation studySabrina Barriere, Céline Bourgne, Thomas Tassin, et al.
American Journal of Hematology|January 29, 2020
Semaphorin 7A: A novel marker of disease activity in Gaucher diseaseMélanie Franco, Nelly Reihani, Lucie Dupuis, et al.
Leukemia Research|January 24, 2015
Phosphorylation of spleen tyrosine kinase at tyrosine 348 (pSyk³⁴⁸) may be a marker of advanced phase of Chronic Myeloid Leukemia (CML)Céline Bourgne, Alexandre Janel, Juliette Berger, et al.
Annals of Hematology|January 23, 2025
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitorsManon Garcia, Carolyne Croizier, Grégory Lazarian, et al.
Annals of Hematology|August 30, 2022
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatorySandrine Saugues, Céline Lambert, Elisabeth Daguenet, et al.
Haematologica|April 21, 2019
Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy studyTatiana Raskovalova, Marc G Berger, Marie-Christine Jacob, et al.
British Journal of Haematology|March 3, 2024
Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-upBenjamin Lebecque, Joevin Besombes, Louis-Thomas Dannus, et al.
Pageof 6